A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells.

NF-κB bone cancer cancer stem cells colon cancer glioblastoma multiforme lung cancer multiple myeloma ovarian cancer pediatric cancer prostate cancer

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
11 May 2019
Historique:
received: 11 03 2019
revised: 02 05 2019
accepted: 08 05 2019
entrez: 15 5 2019
pubmed: 15 5 2019
medline: 15 5 2019
Statut: epublish

Résumé

Cancer stem cells (CSCs) account for tumor initiation, invasiveness, metastasis, and recurrence in a broad range of human cancers. Although being a key player in cancer development and progression by stimulating proliferation and metastasis and preventing apoptosis, the role of the transcription factor NF-κB in cancer stem cells is still underestimated. In the present review, we will evaluate the role of NF-κB in CSCs of glioblastoma multiforme, ovarian cancer, multiple myeloma, lung cancer, colon cancer, prostate cancer, as well as cancer of the bone. Next to summarizing current knowledge regarding the presence and contribution of CSCs to the respective types of cancer, we will emphasize NF-κB-mediated signaling pathways directly involved in maintaining characteristics of cancer stem cells associated to tumor progression. Here, we will also focus on the status of NF-κB-activity predominantly in CSC populations and the tumor mass. Genetic alterations leading to NF-κB activity in glioblastoma, ependymoma, and multiple myeloma will be discussed.

Identifiants

pubmed: 31083587
pii: cancers11050655
doi: 10.3390/cancers11050655
pmc: PMC6563002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Science. 2001 Aug 24;293(5534):1495-9
pubmed: 11520989
J Clin Oncol. 2002 Mar 1;20(5):1248-59
pubmed: 11870167
Ann Surg. 2002 Aug;236(2):203-7
pubmed: 12170025
Br J Surg. 2002 Sep;89(9):1142-9
pubmed: 12190680
Cancer Res. 2003 Sep 15;63(18):5821-8
pubmed: 14522905
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83
pubmed: 14645703
J Clin Invest. 2004 Aug;114(4):569-81
pubmed: 15314694
Oncogene. 2004 Sep 20;23(43):7267-73
pubmed: 15378086
Cancer Cell. 2004 Sep;6(3):297-305
pubmed: 15380520
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
N Engl J Med. 2005 Mar 10;352(10):997-1003
pubmed: 15758010
Nat Rev Cancer. 2005 Apr;5(4):311-21
pubmed: 15803157
Cell. 2005 Jun 17;121(6):811-3
pubmed: 15960966
Cell. 2005 Jun 17;121(6):823-35
pubmed: 15960971
J Clin Oncol. 2005 Nov 1;23(31):7919-26
pubmed: 16258091
Immunity. 2006 Jun;24(6):729-39
pubmed: 16782029
Cancer Res. 2006 Dec 1;66(23):11432-40
pubmed: 17145890
J Natl Cancer Inst. 2006 Dec 6;98(23):1694-706
pubmed: 17148771
Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62
pubmed: 17183360
Prog Mol Subcell Biol. 2007;45:205-25
pubmed: 17585502
Ann Surg Oncol. 2007 Dec;14(12):3581-92
pubmed: 17899287
J Cell Biochem. 2008 Jun 1;104(3):733-44
pubmed: 18253935
Gastroenterology. 2008 May;134(5):1296-310
pubmed: 18471507
Cell. 2008 May 16;133(4):704-15
pubmed: 18485877
Genome Biol. 2008;9(5):R83
pubmed: 18492237
Int J Cancer. 1991 Aug 19;49(1):50-6
pubmed: 1874569
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13427-32
pubmed: 18765800
Colorectal Dis. 2009 May;11(4):354-64; discussion 364-5
pubmed: 19016817
J Clin Oncol. 2009 Mar 20;27(9):1419-25
pubmed: 19224846
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Stem Cells. 2009 Oct;27(10):2393-404
pubmed: 19658188
Nature. 2009 Sep 24;461(7263):495-500
pubmed: 19741607
Methods Mol Biol. 2009;590:363-75
pubmed: 19763516
Cell. 2009 Nov 13;139(4):693-706
pubmed: 19878981
Int J Biochem Cell Biol. 2010 Apr;42(4):519-23
pubmed: 20026420
Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034
pubmed: 20066092
Cold Spring Harb Perspect Biol. 2009 Sep;1(3):a001271
pubmed: 20066105
Clin Cancer Res. 2010 Feb 1;16(3):800-13
pubmed: 20103663
Oncol Rep. 2010 Mar;23(3):725-32
pubmed: 20127012
Stem Cells Dev. 2010 Jul;19(7):999-1015
pubmed: 20184430
PLoS Biol. 2010 Feb 23;8(2):e1000319
pubmed: 20186265
Gastroenterology. 2010 Jun;138(6):2029-2043.e10
pubmed: 20420944
Gastroenterology. 2010 Jun;138(6):2101-2114.e5
pubmed: 20420949
Cold Spring Harb Perspect Biol. 2010 Jun;2(6):a000109
pubmed: 20516126
Oncol Rep. 2010 Aug;24(2):501-5
pubmed: 20596639
Ann Neurol. 2010 Aug;68(2):264-9
pubmed: 20695020
Cancer Res. 2010 Oct 1;70(19):7360-4
pubmed: 20823151
N Engl J Med. 2011 Feb 17;364(7):627-37
pubmed: 21175304
Mol Cells. 2011 Jan;31(1):9-15
pubmed: 21193962
Front Biosci (Landmark Ed). 2011 Jan 01;16:1172-85
pubmed: 21196225
Nat Commun. 2011 Jan 18;2:162
pubmed: 21245843
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer Res. 2011 Jun 15;71(12):4055-60
pubmed: 21628493
Cell. 2011 Jun 10;145(6):926-40
pubmed: 21663795
CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36
pubmed: 21685461
Arch Immunol Ther Exp (Warsz). 2011 Oct;59(5):335-51
pubmed: 21786215
Cell Res. 2012 Jan;22(1):90-106
pubmed: 21876555
Nucleic Acids Res. 2012 Jan;40(1):181-95
pubmed: 21908405
Oncogene. 2012 May 3;31(18):2270-82
pubmed: 21927024
N Engl J Med. 1990 Nov 1;323(18):1228-33
pubmed: 2215606
N Engl J Med. 2011 Dec 29;365(26):2484-96
pubmed: 22204725
Stem Cells. 2012 Apr;30(4):655-64
pubmed: 22232084
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4910-5
pubmed: 22411819
Stem Cells. 2012 Oct;30(10):2309-19
pubmed: 22887854
PLoS One. 2012;7(9):e46665
pubmed: 23029563
Mol Cell. 2012 Dec 14;48(5):771-84
pubmed: 23123196
Neuro Oncol. 2013 Jan;15(1):4-27
pubmed: 23136223
Neurotoxicology. 2013 Mar;35:1-14
pubmed: 23261424
Cell. 2013 Jan 17;152(1-2):25-38
pubmed: 23273993
Oncogene. 2014 Feb 6;33(6):713-723
pubmed: 23435429
Cancer Epidemiol. 2013 Aug;37(4):512-7
pubmed: 23545383
Biochim Biophys Acta. 2013 Aug;1833(8):1894-903
pubmed: 23557785
J Carcinog. 2013 Mar 16;12:6
pubmed: 23599688
Mol Cancer. 2013 Aug 02;12:86
pubmed: 23915189
Nat Commun. 2013;4:2299
pubmed: 23934482
Curr Opin Neurol. 2013 Dec;26(6):701-7
pubmed: 24152818
JAMA. 2013 Nov 6;310(17):1842-50
pubmed: 24193082
Nature. 2014 Feb 27;506(7489):451-5
pubmed: 24553141
Acta Neuropathol. 2014 Apr;127(4):609-11
pubmed: 24562983
Int J Cancer. 2014 May 15;134(10):2489-503
pubmed: 24615157
Int J Cancer. 2014 Oct 15;135(8):1800-11
pubmed: 24623448
Cell. 2014 Apr 24;157(3):580-94
pubmed: 24726434
Lancet. 2014 Dec 6;384(9959):2027-35
pubmed: 25108889
Mol Med Rep. 2014 Nov;10(5):2495-504
pubmed: 25119644
Neuro Oncol. 2015 Jan;17(1):45-52
pubmed: 25140036
Genes Dev. 2014 Sep 1;28(17):1929-39
pubmed: 25184679
Cancer Immunol Res. 2014 Sep;2(9):823-30
pubmed: 25187272
Stem Cells Dev. 2015 Feb 15;24(4):405-16
pubmed: 25382732
Cell Rep. 2014 Dec 11;9(5):1812-1826
pubmed: 25464848
Acta Neuropathol. 2015 Jun;129(6):829-48
pubmed: 25943888
Lancet. 2015 Jul 18;386(9990):249-57
pubmed: 26002111
Ann Transl Med. 2015 May;3(7):95
pubmed: 26015937
Cancer Med. 2015 Sep;4(9):1334-43
pubmed: 26108458
Genes Dev. 2015 Jun 15;29(12):1203-17
pubmed: 26109046
Front Oncol. 2015 Jul 20;5:159
pubmed: 26258069
Gastroenterology. 2015 Dec;149(7):1884-1895.e4
pubmed: 26261008
Int J Cancer. 2016 Apr 1;138(7):1709-18
pubmed: 26519239
Oncogene. 2016 Jun 30;35(26):3476-84
pubmed: 26522720
Sci Rep. 2015 Nov 13;5:16578
pubmed: 26564738
Front Oncol. 2015 Nov 16;5:251
pubmed: 26636033
Neuro Oncol. 2016 Jan;18 Suppl 1:i1-i50
pubmed: 26705298
Br J Cancer. 2016 Jan 12;114(1):1-6
pubmed: 26757421
Cancer Cell. 2016 Feb 8;29(2):201-13
pubmed: 26859459
J Clin Oncol. 2016 May 10;34(14):1611-9
pubmed: 26976423
Cancer Lett. 2016 Jun 28;376(1):137-47
pubmed: 27033454
Proc Natl Acad Sci U S A. 2016 May 3;113(18):5065-70
pubmed: 27099294
Cells. 2016 May 04;5(2):null
pubmed: 27153093
Thorac Cancer. 2016 Jul;7(4):415-21
pubmed: 27385983
Blood. 2016 Sep 1;128(9):1226-33
pubmed: 27458004
Front Immunol. 2016 Sep 22;7:378
pubmed: 27713747
Oncotarget. 2016 Oct 25;7(43):69173-69187
pubmed: 27732951
Cold Spring Harb Perspect Biol. 2017 Jan 3;9(1):null
pubmed: 27836834
Cancer Lett. 2017 Feb 1;386:189-195
pubmed: 27894960
Haematologica. 2016 Dec;101(12):1451-1459
pubmed: 27903712
Nat Rev Clin Oncol. 2017 Jul;14(7):434-452
pubmed: 28031556
Neurotherapeutics. 2017 Apr;14(2):372-384
pubmed: 28374184
Haematologica. 2017 Sep;102(9):1617-1625
pubmed: 28550183
Biomedicines. 2017 Jun 09;5(2):
pubmed: 28598356
Sci Rep. 2017 Jul 7;7(1):4915
pubmed: 28687755
Genes Dev. 2017 Jun 15;31(12):1212-1227
pubmed: 28724615
PLoS One. 2017 Aug 2;12(8):e0182373
pubmed: 28767691
J Extracell Vesicles. 2017 Aug 8;6(1):1359479
pubmed: 28815003
Lancet Oncol. 2017 Oct;18(10):1373-1385
pubmed: 28844499
Prostate. 2017 Oct;77(14):1389-1400
pubmed: 28845520
Cell. 2017 Sep 7;170(6):1096-1108.e13
pubmed: 28886380
Arch Med Res. 2017 May;48(4):343-351
pubmed: 28886875
Cancer Res. 2017 Dec 15;77(24):6927-6940
pubmed: 29074539
Oncotarget. 2017 Sep 8;8(43):75756-75766
pubmed: 29088907
N Engl J Med. 2017 Nov 16;377(20):1954-1963
pubmed: 29141164
Nat Rev Immunol. 2018 May;18(5):309-324
pubmed: 29379212
J Neurochem. 2018 Mar;144(6):780-790
pubmed: 29480969
Biomedicines. 2018 Mar 19;6(1):null
pubmed: 29562713
N Engl J Med. 2018 Mar 29;378(13):1177-1188
pubmed: 29590544
Biomedicines. 2018 Mar 30;6(2):null
pubmed: 29601548
Biochim Biophys Acta Mol Cell Res. 2018 Aug;1865(8):1025-1033
pubmed: 29630899
Biomedicines. 2018 Apr 17;6(2):null
pubmed: 29673141
Oncotarget. 2018 Apr 17;9(29):20631-20639
pubmed: 29755677
PLoS One. 2018 May 29;13(5):e0198223
pubmed: 29813121
Front Oncol. 2018 May 17;8:166
pubmed: 29868483
Adv Clin Exp Med. 2018 Jul;27(7):1017-1020
pubmed: 29938937
Cell Rep. 2018 Jun 26;23(13):3787-3797
pubmed: 29949764
Nucleic Acids Res. 2019 Jan 8;47(D1):D590-D595
pubmed: 30321428
Annu Rev Immunol. 2019 Apr 26;37:145-171
pubmed: 30526160
N Engl J Med. 2018 Dec 13;379(24):2319-2329
pubmed: 30575473
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Medicine (Baltimore). 2019 Feb;98(5):e14290
pubmed: 30702598
Genes (Basel). 2019 Feb 01;10(2):null
pubmed: 30717284
Lancet. 2019 Feb 16;393(10172):678-688
pubmed: 30782343
Cell Death Discov. 2019 Mar 4;5:72
pubmed: 30854231
Cell Death Dis. 2019 Mar 19;10(4):268
pubmed: 30890700
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9453-9462
pubmed: 30910960
J Neurosurg. 1967 Nov;27(5):388-400
pubmed: 4293835
Obstet Gynecol. 1983 Apr;61(4):413-20
pubmed: 6828269
Nature. 1994 Feb 17;367(6464):645-8
pubmed: 7509044
Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9618-22
pubmed: 7568184
Science. 1995 Oct 13;270(5234):286-90
pubmed: 7569976
Cancer. 1993 Jan 15;71(2 Suppl):573-81
pubmed: 8420679
Blood. 1997 Mar 1;89(5):1824-33
pubmed: 9057669
Nat Med. 1997 Jul;3(7):730-7
pubmed: 9212098

Auteurs

Christian Kaltschmidt (C)

Department of Cell Biology, Bielefeld University, Universitätsstrasse 25, 33615 Bielefeld, Germany. c.kaltschmidt@uni-bielefeld.de.

Constanze Banz-Jansen (C)

Department of Gynecology and Obstetrics, and Perinatal Center, Protestant Hospital of Bethel Foundation, Burgsteig 13, 33617 Bielefeld, Germany. Constanze.Banz-Jansen@evkb.de.

Tahar Benhidjeb (T)

Department of General and Visceral Surgery, Protestant Hospital of Bethel Foundation, Schildescher Strasse 99, 33611 Bielefeld, Germany. tahar.benhidjeb@evkb.de.

Morris Beshay (M)

Department for Thoracic Surgery and Pneumology, Protestant Hospital of Bethel Foundation, Burgsteig 13, 33617 Bielefeld, Germany. Morris.Beshay@evkb.de.

Christine Förster (C)

Institute of Pathology, KRH Hospital Nordstadt, Haltenhoffstrasse 41, affiliated with the Protestant Hospital of Bethel Foundation, 30167 Hannover, Germany. Christine.Foerster@evkb.de.

Johannes Greiner (J)

Department of Cell Biology, Bielefeld University, Universitätsstrasse 25, 33615 Bielefeld, Germany. johannes.greiner@uni-bielefeld.de.

Eckard Hamelmann (E)

Children's Center, Protestant Hospital of Bethel Foundation, 33617 Bielefeld, Germany. Eckard.Hamelmann@evkb.de.

Norbert Jorch (N)

Children's Center, Protestant Hospital of Bethel Foundation, 33617 Bielefeld, Germany. norbert.jorch@evkb.de.

Fritz Mertzlufft (F)

Scientific Director, Protestant Hospital of Bethel Foundation, Maraweg 21, 33617 Bielefeld, Germany. Fritz.Mertzlufft@evkb.de.

Jesco Pfitzenmaier (J)

Department of Urology and Center for Computer-assisted and Robotic Urology, Protestant Hospital of Bethel Foundation, Burgsteig 13, 33617 Bielefeld, Germany. Jesco.Pfitzenmaier@evkb.de.

Matthias Simon (M)

Department of Neurosurgery and Epilepsy Surgery, Protestant Hospital of Bethel Foundation, Burgsteig 13, 33617 Bielefeld, Germany. Matthias.Simon@evkb.de.

Jan Schulte Am Esch (J)

Department of General and Visceral Surgery, Protestant Hospital of Bethel Foundation, Schildescher Strasse 99, 33611 Bielefeld, Germany. jan.schulteamesch@evkb.de.

Thomas Vordemvenne (T)

Department of Orthopedics, Trauma Surgery, and Trauma Center, Protestant Hospital of Bethel Foundation, Burgsteig 13, 33617 Bielefeld, Germany. Thomas.Vordemvenne@evkb.de.

Dirk Wähnert (D)

Department of Orthopedics, Trauma Surgery, and Trauma Center, Protestant Hospital of Bethel Foundation, Burgsteig 13, 33617 Bielefeld, Germany. Dirk.Waehnert@evkb.de.

Florian Weissinger (F)

Department of Hematology, Oncology, Internal Medicine, Bone Marrow and Stem Cell Transplantation, Palliative Medicine, and Tumor Center, Protestant Hospital of Bethel Foundation, Burgsteig 13, 33617 Bielefeld, Germany. Florian.Weissinger@evkb.de.

Ludwig Wilkens (L)

Institute of Pathology, KRH Hospital Nordstadt, Haltenhoffstrasse 41, affiliated with the Protestant Hospital of Bethel Foundation, 30167 Hannover, Germany. ludwig.wilkens@krh.eu.

Barbara Kaltschmidt (B)

Department of Cell Biology, Bielefeld University, Universitätsstrasse 25, 33615 Bielefeld, Germany. barbara.kaltschmidt@uni-bielefeld.de.
Molecular Neurobiology, Bielefeld University, Universitätsstrasse 25, 33615 Bielefeld, Germany. barbara.kaltschmidt@uni-bielefeld.de.

Classifications MeSH